Company Overview:
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE” and on the OTCQX under the symbol VRNDF.
[stock_market_chart symbol=”NINE.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Key Share Information:
Current Share Price #N/A
Market Capitalization (in Millions) #N/A
Last Quarter (Share Data) 3/31/2019
Shares Outstanding (in Millions) 86.76
Options (in Millions) 7.20
Warrants (in Millions) 9.15
Fully Diluted (in Millions) 103.11
Enterprise Value (in MIllions) #N/A
TTM Revenue $15.17
TTM Growth Margin % 80.14%
TTM Operating Expenses $26.02
TTM OCF -$6.25
P/S TTM #N/A
P/S (Last Quarter Run Rate) #N/A
Key Balance Sheet Information (in Millions $CAD):
CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ1'19
Cash $0.01 $0.00 $0.00 $0.01 $23.55 $21.25 $13.91 $23.21 $16.23 $7.76
Biological Assets $0.13 $0.22 $0.55 $1.66 $3.79 $6.18
Inventory $0.38 $0.46 $0.34 $2.41 $2.57 $5.19
Total Assets $0.03 $0.02 $0.08 $0.04 $25.04 $23.98 $22.56 $37.87 $45.98 $65.35
Net Tangible Assets $0.03 $0.02 $0.08 $0.04 $25.04 $23.98 $22.56 $37.87 $45.98 $65.35
Intangibles/Goodwill
Total Liabilities $0.15 $0.17 $0.25 $0.30 $0.48 $0.59 $0.50 $1.31 $10.67 $19.28
Key Operating Items (Quarterly in Millions $CAD):
CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ1'19
Revenue $0.94 $0.33 $0.72 $1.25 $7.57 $5.63
Change in Fair Value of Biologial Assets $0.13 $0.09 $0.33 1.22 4.33 $4.06
Gross Margin $0.44 $0.20 $0.66 1.53 5.74 $4.22
Marketing and Sales $0.38 $0.12 $0.27 0.30 2.08 $0.97
Investor Relations $0.39 $0.59 0.83 2.26 $0.03
Total Operating Expenses $0.11 $0.20 $0.02 $0.08 $3.16 $2.13 $2.85 3.76 14.24 $5.17
Operating Cash Flow (Quarterly) -$0.47 -$0.05 -$0.02 -$4.60 -$3.29 -4.44 -0.13 $1.60
Investing Cash Flow (Quarterly) $0.00 $0.00 -$1.47 -$4.31 -2.50 -12.24 $16.35
Financing Cash Flow (Quarterly) $0.48 $0.05 $0.02 $29.50 $0.26 16.24 5.39 -$19.10
Listing Statement